検索条件

閉じる

検索結果 2923 件

タイトル(別表記) A case finding that there was a deemed gift of half interest in real estate( Nagoya District Judgment October 19, 2017, Tax Litigation Document No. 267.)
フルテキストURL olj_72_1_25_31.pdf
著者 岡山公法判例研究会|
出版物タイトル 岡山大學法學會雜誌
発行日 2022-10-28
72巻
1号
開始ページ 25
終了ページ 31
ISSN 0386-3050
言語 日本語
論文のバージョン publisher
フルテキストURL fulltext20221117-1.pdf
著者 Katayama, Yukitoshi| Miura, Ayane| Sakamoto, Tatsuya| Takanami, Keiko| Sakamoto, Hirotaka|
キーワード itchy eyes histamine gastrin-releasing peptide receptor footedness
発行日 2022-10-19
出版物タイトル Proceedings of the Royal Society B: Biological Sciences
289巻
1985号
出版者 The Royal Society
開始ページ 20221126
ISSN 0962-8452
NCID AA00786976
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2022 The Author(s)
論文のバージョン author
PubMed ID 36259204
DOI 10.1098/rspb.2022.1126
Web of Science KeyUT 000872392900003
関連URL isVersionOf https://doi.org/10.1098/rspb.2022.1126
JaLCDOI 10.18926/AMO/64123
フルテキストURL 76_6_723.pdf
著者 Zhang, Quan| Yang, Lixia| Wan, Guozhen| Zhang, Xiaoqiang| Wang, Ying| Zhao, Guannan|
抄録 The diagnostic value of microRNA-377 (miR-377) in patients with acute coronary syndrome (ACS) and explored miR-377’s potential mechanisms. We performed an qRT-PCR to assess serum miR-377 levels in ACS patients and coronary artery ligation rat models. The diagnostic value of miR-377 was evaluated by determining the ROC curve. An ELISA assay was conducted to detect the model rat endothelial damage markers von Willebrand factor (vWF) and heart-type fatty acid binding protein (H-FABP), and proinflammatory cytokines TNF-α, IL-6, and IL-1β. The serum miR-377 level was elevated in the ACS patients and significantly increased in the ACS rats. MiR-377 has a high diagnostic value in ACS patients, with a 0.844 ROC, 76.47% specificity, and 87.10% sensitivity. MiR-377 was positively correlated with the expressions of vWF, H-FABP, cTnI, TNF-α, IL-6, and IL-1β. In ACS rats, reducing the expression of miR-377 significantly inhibited the increases in vWF, H-FABP, TNF-α, IL-6, and IL-1β. An elevated miR-377 level can be used as a diagnostic marker in patients with ACS. A reduction of miR-377 may alleviate ACS by improving myocardial damage such as endothelial injury and the inflammatory response.
キーワード microRNA-377 acute coronary syndrome diagnosis endothelial injury inflammatory
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2022-12
76巻
6号
出版者 Okayama University Medical School
開始ページ 723
終了ページ 730
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Copyright Ⓒ 2022 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 36549775
Web of Science KeyUT 000905195100013
JaLCDOI 10.18926/AMO/64122
フルテキストURL 76_6_715.pdf
著者 Mohammed Zahedul Islam Nizami| Gorduysus, Melahat| Shinoda-Ito, Yuki| Yamamoto, Tadashi| Nishina, Yuta| Takashiba, Shogo| Arias, Zulema|
抄録 The failure of endodontic treatment is directly associated with microbial infection in the root canal or periapical areas. An endodontic sealer that is both bactericidal and biocompatible is essential for the success of root canal treatments. This is one of the vital issues yet to be solved in clinical dental practice. This in vitro study assessed the effectiveness of graphene oxide (GO) composites GO-CaF2 and GO-Ag-CaF2 as endodontic sealer materials. Dentin slices were coated with either the GO-based composites or commonly used root canal sealers (non-eugenol zinc oxide sealer). The coated slices were treated in 0.9% NaCl, phosphate-buffered saline (PBS), and simulated body fluid (SBF) at 37˚C for 24 hours to compare their sealing effect on the dentin surface. In addition, the radiopacity of these composites was examined to assess whether they complied with the requirements of a sealer for good radiographic visualization. Scanning electron microscopy showed the significant sealing capability of the composites as coating materials. Radiographic images confirmed their radiopacity. Mineral deposition indicated their bioactivity, especially of GO-Ag-CaF2, and thus it is potential for regenerative application. They were both previously shown to be bactericidal to oral microbes and cytocompatible with host cells. With such a unique assemblage of critical properties, these GO-based composites show promise as endodontic sealers for protection against reinfection in root canal treatment and enhanced success in endodontic treatment overall.
キーワード bioactive sealer graphene oxide mineral deposition antimicrobial activity radiopacity
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2022-12
76巻
6号
出版者 Okayama University Medical School
開始ページ 715
終了ページ 721
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Copyright Ⓒ 2022 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 36549774
Web of Science KeyUT 000905195100012
JaLCDOI 10.18926/AMO/64121
フルテキストURL 76_6_705.pdf
著者 Higashikawa, Toshihiro| Ito, Tomohiko| Mizuno, Takurou| Ishigami, Keiichiro| Kuroki, Kengo| Maekawa, Naoto| Usuda, Daisuke| Izumida, Toshihide| Yamada, Shinya| Sangen, Ryusho| Hamada, Kazu| Kiyosawa, Jun| Saito, Atsushi| Iguchi, Masaharu| Kasamaki, Yuji| Nakahashi, Takeshi| Fukuda, Akihiro| Saito, Hitoshi| Kanda, Tsugiyasu| Okuro, Masashi|
抄録 The sodium glucose transporter 2 (SGLT2) inhibitor tofogliflozin is a glucose-lowering drug that causes the excretion of surplus glucose by inhibiting SGLT2. Because of tofogliflozin’s osmotic diuresis mechanism, patients’ serum electrolytes, body fluid levels, and cardiac function must be monitored. We retrospectively analyzed the cases of 64 elderly Japanese patients with type 2 diabetes mellitus (T2DM) who received tofogliflozin for 3 months. Their HbA1c, serum electrolytes (sodium, potassium, chloride), hematocrit, brain natriuretic peptide (cardiac volume load marker) and renin and aldosterone (RAA; an index of regulatory hormones involved in body fluid retention) were continuously monitored during the investigation period. Renal function and cardiac function (by echocardiography) were assessed throughout the period. HbA1c significantly decreased (β1=−0.341, p<0.0001, linear regression analysis [LRA]). Most of the hormonal, electrolyte, and physiological parameters were maintained throughout the study period. In these circumstances, E/e’ tended to decrease (β1=−0.382, p=0.13, LRA). Compared to the baseline, E/e’ was significantly decreased at 1 and 3 months (p<0.01, p<0.05). In the higher E/e’ group (E/e’≥10, n=34), E/e’ decreased significantly (β1=−0.63, p<0.05, LRA). ΔE/e’ was correlated with body-weight change during treatment (r=0.64, p<0.01). The 3-month tofogliflozin treatment improved glycemic control and diastolic function represented by E/e’ in T2DM patients, without affecting serum electrolytes, renal function, or RAA. No negative impacts on the patients were observed. Three-month tofogliflozin treatment lowered glucose and improved cardiac diastolic function.
キーワード tofogliflozin SGLT2 inhibitor elderly patient HbA1c cardiac diastolic function
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2022-12
76巻
6号
出版者 Okayama University Medical School
開始ページ 705
終了ページ 713
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Copyright Ⓒ 2022 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 36549773
Web of Science KeyUT 000905195100011
JaLCDOI 10.18926/AMO/64041
フルテキストURL 76_5_593.pdf
著者 Noumi, Taku| Watanabe, Hiromi| Ninomiya, Kiichiro| Ohashi, Kadoaki| Ichihara, Eiki| Kubo, Toshio| Makimoto, Go| Kato, Yuka| Fujii, Masanori| Tabata, Masahiro| Maeda, Yoshinobu| Hotta, Katsuyuki| Kiura, Katsuyuki|
抄録 We encountered a woman with re-enlarged axillary lymph nodes during a computed tomography (CT) scan for surveillance of lung adenocarcinoma with axillary lymph node metastasis at the initial diagnosis that had shrunk with standard chemotherapy. We first suspected cancer recurrence and considered a change in the chemotherapeutic regimen. However, after careful history taking regarding the timing of her Coronavirus Disease 2019 (COVID-19) vaccination, and subsequent careful, close follow-up, radiological shrinkage suggested a strictly benign cause. Especially in lung cancer with a medical history of axillary lymph node involvement, cliniciansshould be aware that vaccine-associated lymphadenopathy can mimic cancer recurrence and sometimesprompt serious misjudgment regarding a current treatment course and strategy.
キーワード lung cancer COVID-19 vaccination axillary lymphadenopathy case report
Amo Type Case Report
出版物タイトル Acta Medica Okayama
発行日 2022-10
76巻
5号
出版者 Okayama University Medical School
開始ページ 593
終了ページ 596
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Copyright Ⓒ 2022 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 36352807
Web of Science KeyUT 000884907100013
JaLCDOI 10.18926/AMO/64040
フルテキストURL 76_5_585.pdf
著者 Choshi, Haruki| Watanabe, Mototsugu| Furukawa, Shinichi| Ujike, Hiroyuki| Kataoka, Kazuhiko|
抄録 Pulmonary metastatic resection is a standard therapy for renal cell carcinoma (RCC). Although patients with pulmonary metastases who do not undergo any treatment have poor prognoses, it has been reported that resection for pulmonary metastases yields good clinical outcomes. We investigated the prognoses of the 10 Japanese patients (eight males, two females) who underwent a surgical resection of pulmonary metastasectomy from RCC at our institution between April 1, 2012 and March 31, 2020 and analyzed the prognostic factors. We determined the prognoses and calculated the 5-year overall survival (OS) and disease-free survival (DFS) rates. To identify prognostic factors, we compared the median DFS duration for each factor. Elderly patients (median age, 75.5 years) were more predominant compared to previous studies, and all 10 patients underwent a complete resection. The 5-year DFS rate was 30.5% (95%CI: 0.045-0.63) and the 5-year OS rate was 80% (95%CI: 0.20-0.97). The following factors were associated with better prognosis: female, disease-free interval≥36 months, and metastases size<12 mm. These results indicate that complete resection for pulmonary metastases from RCC resulted in good clinical outcomes, particularly for patients with better prognostic factors.
キーワード renal cell carcinoma pulmonary metastasis complete resection
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2022-10
76巻
5号
出版者 Okayama University Medical School
開始ページ 585
終了ページ 591
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Copyright Ⓒ 2022 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 36352806
Web of Science KeyUT 000884907100012
JaLCDOI 10.18926/AMO/64039
フルテキストURL 76_5_577.pdf
著者 Okutani, Yuki| Fujita, Hiroshi| Harada, Hideto| Kataoka, Masanao| Murotani, Yoshiki| Shimizu, Yu|
抄録 The prevalence of preoperative deep vein thrombosis (DVT) has been reported to be relatively high in patients undergoing total hip arthroplasty. We investigated the prevalence of DVT, the association between hip function and preoperative DVT, and the effect of a history of surgery in patients who underwent primary total hip arthroplasty. We retrospectively analyzed the cases of the patients who underwent primary total hip arthroplasty between April 2013 and February 2020 at our institution. We evaluated the prevalence of preoperative DVT based on the results of the patients’ ultrasound screening. We performed univariate and multivariate analyses to investigate the association between the incidence of DVT and patient factors including age, sex, hip function, medical histories, and American Society of Anesthesiologists Physical Status classification. We analyzed 451 patients (494 hips). The prevalence of DVT was 14.2% (64 patients). The multivariate analysis demonstrated that increased age was an independent significant risk factor for DVT. The prevalence of preoperative DVT was relatively high among patients who underwent primary total hip arthroplasty. Preoperative DVT tended to be more prevalent in older patients. Hip function was not associated with the incidence of DVT.
キーワード total hip arthroplasty deep vein thrombosis hip function ultrasound screening
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2022-10
76巻
5号
出版者 Okayama University Medical School
開始ページ 577
終了ページ 584
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Copyright Ⓒ 2022 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 36352805
Web of Science KeyUT 000884907100011
JaLCDOI 10.18926/AMO/64037
フルテキストURL 76_5_557.pdf
著者 Pan, Yu| Song, Qingqing| Kanazawa, Tomoyuki| Morimatsu, Hiroshi|
抄録 Some pediatric cardiac patients might experience low regional cerebral oxygen saturation (rSO2) during surgery. We investigated whether a pediatric patient’s mean arterial pressure (MAP) can affect the rSO2 value during cardiopulmonary bypass (CPB). We retrospectively analyzed the cases of the pediatric patients who underwentcardiac surgery at our hospital (Jan. –Dec. 2019; n=141). At each MAP stage, we constructed line charts through the mean of the rSO2 values corresponding to each MAP and then calculated the correlation coefficients. We next divided the patients into age subgroups (neonates, infants, children) and into cyanotic congenital heart disease (CHD) and acyanotic CHD groups and analyzed these groups in the same way. The analyses of all 141 patients revealed that during CPB the rSO2 value increased with an increase in MAP (r=0.1626). There was a correlation between rSO2 and MAP in the children (r=0.2720) but not in the neonates (r=0.06626) or infants (r=0.05260). Cyanotic CHD or acyanotic CHD did not have a significant effect on the rSO2/MAP correlation. Our analysis demonstrated different patterns of a correlation between MAP and rSO2 in pediatric cardiac surgery patients, depending on age. MAP was positively correlated with rSO2 typically in children but not in neonate or infant patients.
キーワード mean arterial pressure cerebral oxygen saturation
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2022-10
76巻
5号
出版者 Okayama University Medical School
開始ページ 557
終了ページ 564
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Copyright Ⓒ 2022 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 36352803
Web of Science KeyUT 000884907100009
JaLCDOI 10.18926/AMO/64036
フルテキストURL 76_5_547.pdf
著者 Kagawa, Hidetoshi| Yamanaka, Ryutaro| Hiromasa, Tsutomu|
抄録 This observational study aimed to clarify the long-term results of the combination of mizoribine (MZB), tacrolimus (TAC) and prednisolone as first-line therapy for lupus nephritis (LN). This was our institution’s standard therapy between 2009 and 2015, when we saw 36 patients with LN. When a patient thus treated achieved SLEDAI remission (= 0) and/or the prednisolone dose could be tapered to 5 mg/day, either MZB or TAC was stopped, and the other was continued for maintenance therapy. If treatment failure or relapse occurred, second-line therapy was introduced. At years 1 and 5, overall complete renal response and SLEDAI remission were 94% and 88%, and 50% and 62%, respectively. Excluding 2 cases lost to follow-up, medications after 5 years were as follows: 20 (59%) were stable on 1 drug (MZB or TAC), 11 (32%) required continuation of both drugs (MZB + TAC), and 3 (9%) required second-line therapy. The 5-year retention rate was 91% (non-secondline), with 0% of relapse in this group. Our first-line combination strategy showed high remission rates in the induction phase, and subsequent maintenance therapy demonstrated good outcomes for up to 5 years. Research that fine-tunes the order of therapeutic agents and institutes appropriate treatment goals may further improve long-term outcomes for patients with LN.
キーワード combination therapy first-line therapy lupus nephritis mizoribine tacrolimus
Amo Type Original Article
出版物タイトル Acta Medica Okayama
発行日 2022-10
76巻
5号
出版者 Okayama University Medical School
開始ページ 547
終了ページ 555
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Copyright Ⓒ 2022 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 36352802
Web of Science KeyUT 000884907100008
フルテキストURL fulltext.pdf
著者 Nakano, Yasuhiro| Otsuka, Yuki| Honda, Hiroyuki| Sunada, Naruhiko| Tokumasu, Kazuki| Sakurada, Yasue| Matsuda, Yui| Hasegawa, Toru| Ochi, Kanako| Hagiya, Hideharu| Kataoka, Hitomi| Ueda, Keigo| Otsuka, Fumio|
キーワード dysgeusia dysosmia myalgic encephalomyelitis/chronic fatigue syndrome Omicron variant and post COVID-19 condition
発行日 2022-10-05
出版物タイトル Medicina-Lithuania
58巻
10号
出版者 MDPI
開始ページ 1393
ISSN 1010-660X
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2022 by the authors.
論文のバージョン publisher
PubMed ID 36295554
DOI 10.3390/medicina58101393
Web of Science KeyUT 000875069800001
関連URL isVersionOf https://doi.org/10.3390/medicina58101393
JaLCDOI 10.18926/AMO/64025
フルテキストURL 76_5_503.pdf
著者 Ogawa, Hirohito| Honda, Tomoyuki|
抄録 Eukaryotic genomes contain numerous copies of endogenous viral elements (EVEs), most of which are considered endogenous retrovirus (ERV) sequences. Over the past decade, non-retroviral endogenous viral elements (nrEVEs) derived from ancient RNA viruses have been discovered. Several functions have been proposed for these elements, including antiviral defense. This review summarizes the current understanding of nrEVEs derived from RNA viruses, particularly endogenous bornavirus-like elements (EBLs) and endogenous filovirus-like elements (EFLs). EBLs are one of the most extensively studied nrEVEs. The EBL derived from bornavirus nucleoprotein (EBLN) is thought to function as a non-coding RNA or protein that regulates host gene expression or inhibits virus propagation. Ebolavirus and marburgvirus, which are filoviruses, induce severe hemorrhagic fever in humans and nonhuman primates. Although the ecology of filoviruses remains unclear, bats are believed to be potential reservoirs. Based on the knowledge from EBLs, it is postulated that EFLs in the bat genome help to maintain the balance between filovirus infection and the bat’s defense system, which may partially explain why bats act as potential reservoirs. Further research into the functions of nrEVEs could reveal novel antiviral systems and inspire novel antiviral approaches.
キーワード EVE nrEVE bornavirus filovirus antiviral
Amo Type Review
出版物タイトル Acta Medica Okayama
発行日 2022-10
76巻
5号
出版者 Okayama University Medical School
開始ページ 503
終了ページ 510
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Copyright Ⓒ 2022 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 36352796
Web of Science KeyUT 000884907100002
JaLCDOI 10.18926/AMO/64024
フルテキストURL 76_5_489.pdf
著者 Matsumoto, Yuji| Ichikawa, Tomotsugu| Kurozumi, Kazuhiko| Date, Isao|
抄録 Glioblastoma (GBM) is a fatal primary malignant brain tumor in adults. Despite decades of research, the prognosis for GBM patients is still disappointing. One major reason for the intense therapeutic resistance of GBM is inter- and intra-tumor heterogeneity. GBM-intrinsic transcriptional profiling has suggested the presence of at least three subtypes of GBM: the proneural, classic, and mesenchymal subtypes. The mesenchymal subtype is the most aggressive, and patients with the mesenchymal subtype of primary and recurrent tumors tend to have a worse prognosis compared with patients with the other subtypes. Furthermore, GBM can shift from other subtypes to the mesenchymal subtype over the course of disease progression or recurrence. This phenotypic transition is driven by diverse tumor-intrinsic molecular mechanisms or microenvironmental factors. Thus, better understanding of the plastic nature of mesenchymal transition in GBM is pivotal to developing new therapeutic strategies. In this review, we provide a comprehensive overview of the current understanding of the elements involved in the mesenchymal transition of GBM and discuss future perspectives.
キーワード glioma glioblastoma mesenchymal subtype mesenchymal transition heterogeneity
Amo Type Review
出版物タイトル Acta Medica Okayama
発行日 2022-10
76巻
5号
出版者 Okayama University Medical School
開始ページ 489
終了ページ 502
ISSN 0386-300X
NCID AA00508441
資料タイプ 学術雑誌論文
言語 英語
著作権者 Copyright Ⓒ 2022 by Okayama University Medical School
論文のバージョン publisher
査読 有り
PubMed ID 36352795
Web of Science KeyUT 000884907100001
フルテキストURL fulltext.pdf
著者 Nakahara, Momoko| Toyama, Naoki| Ekuni, Daisuke| Takeuchi, Noriko| Maruyama, Takayuki| Yokoi, Aya| Fukuhara, Daiki| Sawada, Nanami| Nakashima, Yukiho| Morita, Manabu|
キーワード self-rated oral health oral health behaviors caries gingivitis oral hygiene oral health behavioral sciences
発行日 2022-10-20
出版物タイトル International Journal of Environmental Research and Public Health
19巻
20号
出版者 MDPI
開始ページ 13580
ISSN 1660-4601
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2022 by the authors.
論文のバージョン publisher
PubMed ID 36294160
DOI 10.3390/ijerph192013580
Web of Science KeyUT 000873221100001
関連URL isVersionOf https://doi.org/10.3390/ijerph192013580
フルテキストURL fulltext.pdf
著者 Shigehiro, Tsukasa| Ueno, Maho| Kijihira, Mayumi| Takahashi, Ryotaro| Umemura, Chiho| Taha, Eman A.| Kurosaka, Chisaki| Asayama, Megumi| Murakami, Hiroshi| Satoh, Ayano| Nakamura, Yoshimasa| Futami, Junichiro| Masuda, Junko|
キーワード breast cancer cells dendritic cells mesenteric lymph node myeloid-derived suppressor cells
発行日 2022-09-20
出版物タイトル International Journal Of Molecular Sciences
23巻
19号
出版者 MDPI
開始ページ 11035
ISSN 1422-0067
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2022 by the authors.
論文のバージョン publisher
PubMed ID 36232335
DOI 10.3390/ijms231911035
Web of Science KeyUT 000867767200001
関連URL isVersionOf https://doi.org/10.3390/ijms231911035
フルテキストURL fulltext.pdf
著者 Miyoshi, Tomoko| Ida, Hiromi| Nishimura, Yoshito| Ako, Soichiro| Otsuka, Fumio|
キーワード stress burnout yoga mindfulness stress in healthcare workers self-compassion the COVID-19 pandemic
発行日 2022-09-30
出版物タイトル International Journal Of Environmental Research and Public Health
19巻
19号
出版者 MDPI
開始ページ 12523
ISSN 1660-4601
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2022 by the authors.
論文のバージョン publisher
PubMed ID 36231820
DOI 10.3390/ijerph191912523
Web of Science KeyUT 000868048000001
関連URL isVersionOf https://doi.org/10.3390/ijerph191912523
フルテキストURL fulltext.pdf
著者 Tokumitsu, Hiroshi| Sakagami, Hiroyuki|
キーワード CaMKK CaM-kinase cascade Ca2+ signaling phosphorylation
発行日 2022-09-20
出版物タイトル INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
23巻
19号
出版者 MDPI
開始ページ 11025
ISSN 1422-0067
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2022 by the authors.
論文のバージョン publisher
PubMed ID 36232320
DOI 10.3390/ijms231911025
Web of Science KeyUT 000867778400001
関連URL isVersionOf https://doi.org/10.3390/ijms231911025
フルテキストURL fulltext.pdf
著者 Fu, Jingwen| Kosaka, Junko| Morimatsu, Hiroshi|
キーワード acute kidney injury KDIGO definition serum creatine urine output early identification
発行日 2022-09-23
出版物タイトル JOURNAL OF CLINICAL MEDICINE
11巻
19号
出版者 MDPI
開始ページ 5589
ISSN 2077-0383
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2022 by the authors.
論文のバージョン publisher
PubMed ID 36233456
DOI 10.3390/jcm11195589
Web of Science KeyUT 000867903000001
関連URL isVersionOf https://doi.org/10.3390/jcm11195589
フルテキストURL fulltext.pdf
著者 Wang, Dengli| Ousaka, Daiki| Qiao, Handong| Wang, Ziyi| Zhao, Kun| Gao, Shangze| Liu, Keyue| Teshigawara, Kiyoshi| Takada, Kenzo| Nishibori, Masahiro|
キーワード intracerebral hemorrhage HMGB1 antibody therapy non-human primate
発行日 2022-09-23
出版物タイトル Cells
11巻
19号
出版者 MDPI
開始ページ 2970
ISSN 2073-4409
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2022 by the authors.
論文のバージョン publisher
PubMed ID 36230933
DOI 10.3390/cells11192970
Web of Science KeyUT 000866922400001
関連URL isVersionOf https://doi.org/10.3390/cells11192970
フルテキストURL fulltext.pdf
著者 Togo, Hidetoshi| Asanuma, Kohei| Nishi, Tatsushi| Liu, Ziang|
キーワード multi-objective scheduling estimation weighting factors machine learning simulated annealing inverse optimization
発行日 2022-09-21
出版物タイトル Applied Sciences - Basel
12巻
19号
出版者 MDPI
開始ページ 9472
ISSN 2076-3417
資料タイプ 学術雑誌論文
言語 英語
OAI-PMH Set 岡山大学
著作権者 © 2022 by the authors.
論文のバージョン publisher
DOI 10.3390/app12199472
Web of Science KeyUT 000866634100001
関連URL isVersionOf https://doi.org/10.3390/app12199472